Natera

YTD

ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).

CEO

Stephen Leonard Chapman

CEOStephen Leonard Chapman

Employees

6,140

Employees6,140

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2003

Founded2003

Employees

6,140

Employees6,140

NTRA Key Statistics

Market cap

47.27B

Market cap47.27B

Price-Earnings ratio

-239.42

Price-Earnings ratio-239.42

Dividend yield

—

Dividend yield—

Average volume

1.11M

Average volume1.11M

High today

$329.05

High today$329.05

Low today

$323.42

Low today$323.42

Open price

$323.92

Open price$323.92

Volume

794.16K

Volume794.16K

52 Week high

$343.18

52 Week high$343.18

52 Week low

$157.43

52 Week low$157.43

Stock Snapshot

With a market cap of 47.27B, Natera(NTRA) trades at $328.18. The stock has a price-to-earnings ratio of -239.42.

On 2026-09-04, Natera(NTRA) stock moved within a range of $323.42 to $329.05. With shares now at $328.18, the stock is trading +1.5% above its intraday low and -0.3% below the session's peak.

Trading volume for Natera(NTRA) stock has reached 794.16K, versus its average volume of 1.11M.

Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $343.18 and a low of $157.43.

NTRA News

Investing.com 19h

Natera president Solomon Moshkevich sells over $5.9m in shares - Investing.com

...

TipRanks 3d

Natera announces publication of new data in Blood Neoplasia on Signatera

Natera (NTRA) announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients with both newly...

Nasdaq 7d

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?

Key Points Natera ranks as the top holding in Druckenmiller's Duquesne Family Office portfolio. The diagnostics company continues to generate strong growth, e...

Analyst ratings

83%

of 24 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

iShares MSCI Emerging Mar…

Modine

CSX

Alcoa

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.